Literature DB >> 21193176

The relationship between alexithymia and psychological factors in systemic lupus erythematosus.

Filipe Barbosa1, Catarina Mota, Patrícia Patrício, Cristina Alcântara, Carlos Ferreira, António Barbosa.   

Abstract

BACKGROUND: Alexithymia has been described as an important dimension in several medical diseases. Systemic lupus erythematosus (SLE) is a chronic condition characterized by unpredictable clinical manifestations. Our aim is to reveal which factors (psychological factors and quality of life dimensions) are associated with alexithymia in SLE patients.
METHODS: Fifty-three sequential SLE patients (ACR criteria) and 41 asthma patients were studied by means of validated scales for alexithymia (Toronto Alexithymia Scale), psychopathology (Brief Symptom Inventory, Hospital Anxiety and Depression Scale), personality dimensions (NEO-FFI), and quality of life (Short Form-36 Health Survey). Systemic lupus erythematosus patient's clinical and laboratorial evaluation was performed by indicators of activity (Systemic Lupus Erythematosus Disease Activity Index) of accumulated damage (Systemic Lupus International Collaborating Clinics/ACR Damage Index), length of disease, and therapy.
RESULTS: An association between alexithymia and psychopathological symptoms, and personality and quality of life dimensions was found. By means of multiple regression analysis, openness and depression were the 2 predictors for alexithymia in SLE patients. We found a high prevalence rate of alexithymia in SLE patients; however, when controlling for depression symptoms (Hospital Anxiety and Depression Scale-Depression, <7), we found a lower percentage of alexithymic traits than that of the total sample of SLE.
CONCLUSION: Alexithymia was associated with psychological distress and with quality of life impairment. Understanding the role of psychological factors in SLE patients may contribute to a more comprehensive perspective of the disease, its impact on patient's daily routine, and how patients adapt emotionally to a chronic disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21193176     DOI: 10.1016/j.comppsych.2010.11.004

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  6 in total

1.  Factors related to alexithymia in patients with systemic sclerosis: a tight relationship with facial image dissatisfaction.

Authors:  Fabio Basta; Domenico Paolo Emanuele Margiotta; Carmen Mazzuca; Veronica Batani; Giulio Dolcini; Patrizio Moras; Marta Vadacca; Antonella Afeltra
Journal:  Rheumatol Int       Date:  2018-11-29       Impact factor: 2.631

2.  Alexithymia, mood states and pain experience in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Marta Vadacca; Rosa Bruni; Nicolò Terminio; Gianluca Sambataro; Domenico Margiotta; Francesco Maria Serino; Antonella Afeltra
Journal:  Clin Rheumatol       Date:  2014-04-11       Impact factor: 2.980

3.  Psychometric properties of the Brief Symptom Inventory in nomophobic subjects: insights from preliminary confirmatory factor, exploratory factor, and clustering analyses in a sample of healthy Italian volunteers.

Authors:  Mohammad Adawi; Riccardo Zerbetto; Tania Simona Re; Bishara Bisharat; Mahmud Mahamid; Howard Amital; Giovanni Del Puente; Nicola Luigi Bragazzi
Journal:  Psychol Res Behav Manag       Date:  2019-03-12

4.  Predictors of stress in patients with Lupus.

Authors:  Meenakshi Jolly; Patricia Katz
Journal:  Front Med (Lausanne)       Date:  2022-09-29

5.  Psychometric Properties of the Bermond-Vorst Alexithymia Questionnaire (BVAQ) in the General Population and a Clinical Population.

Authors:  Lars de Vroege; Wilco H M Emons; Klaas Sijtsma; Christina M van der Feltz-Cornelis
Journal:  Front Psychiatry       Date:  2018-04-23       Impact factor: 4.157

6.  Ability to Participate in Social Activities of Rheumatoid Arthritis Patients Compared with Other Rheumatic Diseases: A Cross-Sectional Observational Study.

Authors:  Laura Cano-García; Natalia Mena-Vázquez; Sara Manrique-Arija; Rocío Redondo-Rodriguez; Carmen María Romero-Barco; Antonio Fernández-Nebro
Journal:  Diagnostics (Basel)       Date:  2021-12-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.